Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06239064

Early Genetic Identification of Obesity

Whole Genetic Approach in Early Genetic Identification of Obesity (WEGIO)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Rolfs Consulting und Verwaltungs-GmbH (RCV) · Network
Sex
All
Age
2 Years
Healthy volunteers

Summary

TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO) DESIGN: Multicenter epidemiological study STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS) NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs

Detailed description

TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO) DESIGN: Multicenter epidemiological study STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS) NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs PARTICIPATING COUNTRY: Germany TREATMENT: Not applicable PRIMARY OBJECTIVE: To investigate the prevalence of BBS in an at-risk population SECONDARY OBJECTIVES: * To explore genotype-phenotype correlation * To assess genotypes distribution in Germany and compare to other countries * To identify new genes/variants * To investigate clinical characteristics in individuals diagnosed with BBS DURATION OF RECRUITMENT: 32 months - total 24 months the recruitment of 1000 subjects 27 months follow up visits 32 months close out of sites INCLUSION CRITERIA: * Informed consent is obtained from the participant/parent/legal guardian * The participant is 2 years of age or older For a participant between 2 and 18 years of age: * The participant has and had a body weight more than 97th percentile before the age of 6 * The participant has one or more of the following symptoms: rod/cone dystrophy, renal abnormalities, ataxia, syndactyly, polydactyly, brachydactyly, hyperphagia, cognitive impairment, speech delay, hypogonadism For a participant who is 18 years of age or older: * The participant has BMI ≥ 30 kg/m2 * The participant had a body weight more than 97th percentile before the age of 6 years * The participant has rod/cone dystrophy * The participant is 2 or more years of age, is clinically diagnosed with Bardet-Biedl-Syndrome (BBS) or is a sibling of an individual diagnosed with BBS via the WEGIO study

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGenetic testing via blood collectionblood collection

Timeline

Start date
2024-01-24
Primary completion
2026-03-01
Completion
2027-03-01
First posted
2024-02-02
Last updated
2025-09-29

Locations

37 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT06239064. Inclusion in this directory is not an endorsement.